Gollnick SO - Search Results

1

Photodynamic therapy of cancer: an update.

Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J. Agostinis P, et al. Among authors: gollnick so. CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81. doi: 10.3322/caac.20114. Epub 2011 May 26. CA Cancer J Clin. 2011. PMID: 21617154 Free PMC article. Review.

2

Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils.

Kousis PC, Henderson BW, Maier PG, Gollnick SO. Kousis PC, et al. Among authors: gollnick so. Cancer Res. 2007 Nov 1;67(21):10501-10. doi: 10.1158/0008-5472.CAN-07-1778. Cancer Res. 2007. PMID: 17974994 Free PMC article.

3

Photodynamic therapy and antitumor immunity.

Gollnick SO. Gollnick SO. J Natl Compr Canc Netw. 2012 Oct 1;10 Suppl 2(0 2):S40-3. doi: 10.6004/jnccn.2012.0173. J Natl Compr Canc Netw. 2012. PMID: 23055214 Free PMC article.

4

Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions.

Shafirstein G, Battoo A, Harris K, Baumann H, Gollnick SO, Lindenmann J, Nwogu CE. Shafirstein G, et al. Among authors: gollnick so. Ann Am Thorac Soc. 2016 Feb;13(2):265-75. doi: 10.1513/AnnalsATS.201509-650FR. Ann Am Thorac Soc. 2016. PMID: 26646726 Free PMC article. Review.

5

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.

Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, Cheney RT, Morgan J. Henderson BW, et al. Among authors: gollnick so. Cancer Res. 2004 Mar 15;64(6):2120-6. doi: 10.1158/0008-5472.can-03-3513. Cancer Res. 2004. PMID: 15026352

6

Photodynamic therapy and anti-tumor immunity.

Gollnick SO, Owczarczak B, Maier P. Gollnick SO, et al. Lasers Surg Med. 2006 Jun;38(5):509-15. doi: 10.1002/lsm.20362. Lasers Surg Med. 2006. PMID: 16788921

7

CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.

Kabingu E, Vaughan L, Owczarczak B, Ramsey KD, Gollnick SO. Kabingu E, et al. Among authors: gollnick so. Br J Cancer. 2007 Jun 18;96(12):1839-48. doi: 10.1038/sj.bjc.6603792. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505510 Free PMC article.

8

Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease.

Shams M, Owczarczak B, Manderscheid-Kern P, Bellnier DA, Gollnick SO. Shams M, et al. Among authors: gollnick so. Cancer Immunol Immunother. 2015 Mar;64(3):287-97. doi: 10.1007/s00262-014-1633-9. Epub 2014 Nov 11. Cancer Immunol Immunother. 2015. PMID: 25384911 Free PMC article.

9

Photodynamic Therapy and Immunity: An Update.

Falk-Mahapatra R, Gollnick SO. Falk-Mahapatra R, et al. Among authors: gollnick so. Photochem Photobiol. 2020 May;96(3):550-559. doi: 10.1111/php.13253. Epub 2020 Apr 23. Photochem Photobiol. 2020. PMID: 32128821 Free PMC article. Review.

10

Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.

Bellnier DA, Gollnick SO, Camacho SH, Greco WR, Cheney RT. Bellnier DA, et al. Among authors: gollnick so. Cancer Res. 2003 Nov 15;63(22):7584-90. Cancer Res. 2003. PMID: 14633671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page